The Clinical Trial Modernization Act (S.4440) is an early-stage bill authorizing grants for clinical trial outreach to underrepresented populations. It has no specific funding amount and has only been referred to committee, so near-term market impact is minimal. The bill is neutral for the healthcare sector until appropriations are made.
TICKER INTELLIGENCE
$IQV
Company & Legislative Profile
$IQV is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 6 active Congressional signals mentioning $IQV, including 3 bills and 3 federal contracts. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
$IQV is currently facing 6 active congressional signals and 3 federal contracts tracked by HillSignal. With 3 bullish, 1 neutral, and 2 bearish signals, covering 2 sectors. Key sectors affected include Healthcare and Technology. Recent major catalysts include THE LEWIN GROUP, INC.: $11.3M Department of Health and Human Services Contract and TRIWEST HEALTHCARE ALLIANCE CORP: $28.3M Department of Veterans Affairs Contract. Below is the complete tracker of government activity affecting $IQV’s market performance.
6
Total Signals
4.0/10
Avg Impact
3
Bullish Signals
2
Bearish Signals
Related Sectors
Recent Congressional Signals for $IQV
This $16.6 million contract to Oak Ridge Associated Universities, a private entity, supports NIOSH's responsibilities under the EEOICPA, indicating a steady demand for specialized health services within the federal government. While not directly impacting publicly traded companies, it reflects ongoing federal investment in healthcare-related research and support services.
The Lewin Group, a subsidiary of Optum (UnitedHealth Group), secured an $11.3M contract from CMS for long-term healthcare innovation support, signaling continued federal investment in healthcare modernization. This award is particularly relevant given the recent Executive Order on accelerating medical treatments for serious mental illness, which could drive further demand for such support services.
This $28.3 million Department of Veterans Affairs contract to TriWest Healthcare Alliance Corp. for an "Express Report" is bullish for the healthcare sector, particularly for managed care organizations. While TriWest is private, this award signals continued federal investment in veteran healthcare services, benefiting publicly traded peers and potential partners.
CARGO Act of 2025
BEARISHThe CARGO Act of 2025, an early-stage Senate bill, would ban NIH funding for animal research conducted outside the U.S., redirecting $2.2B from international to domestic facilities. Over the past 7 days, $CRL has fallen -2.88% and $IQV has fallen -1.6%, reflecting the market pricing in this legislative headwind for CROs with international exposure.
HR7165 (WATCH Act) imposes quarterly inspection mandates on foreign labs conducting NIH-funded animal research, targeting CROs like IQVIA and CRL. Both stocks have declined sharply in the last week, with IQVI down 2.49% and CRL down 3.4% over 7 days, reflecting sector weakness amplified by this regulatory overhang. The bill is early-stage and authorized no new funding, but its compliance costs would pressure margins if enacted.
Understanding These Signals
Get Full Access to $IQV Signals
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →